Drug comparisons
Troglitazone vs Lixisenatide
Troglitazone (withdrawn TZD for liver toxicity) vs Lixisenatide (GLP-1 agonist). Compare safety, uses, and why one is obsolete.
No comparison dimensions are available for this page.
Clinical context
Triggered by patients reviewing discontinued diabetes drugs against current GLP-1 options like those in Soliqua.
Bottom line
Lixisenatide is the only viable choice since Troglitazone was withdrawn for safety reasons.
All medication comparisons